BridgeBio Pharma, Inc. Share Price

BridgeBio Pharma, Inc. Share Price

NASDAQ: BBIO | Large Cap
$76.78
-$0.59 (-0.76%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

BridgeBio Pharma, Inc. Stock Performance

Open
$76.57
Prev. Close
$77.37
Circuit Range
N/A
Day Range
$74.82 - $76.99
Year Range
$62.53 - $93.17
Volume
1,44,746
Average Traded
$76.11

BridgeBio Pharma, Inc. Share Price Today

As of 18 November 2026, BridgeBio Pharma, Inc.'s share price is $76.78. The stock opened at $76.57, compared to its previous close of $77.37. During today's trading session, BridgeBio Pharma, Inc.'s share price traded between $74.82 and $76.99, with an average price of $75.91. Over the past 52 weeks, the stock has recorded a high of $93.17 and a low of $62.53. In terms of performance, BridgeBio Pharma, Inc.'s share price has risen by 15.77% over the last six months and is up 6.62% on a year-on-year basis.

BridgeBio Pharma, Inc. Share Price Chart

Line chart of the BridgeBio Pharma, Inc. price trend over the selected period. The price fell overall, ranging from 74.89 to 77.10, ending at 76.78.
$74.82$76.99
L
Show Current Price
H

BridgeBio Pharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$14.71B
PE Ratio (TTM)
N/A
Dividend Yield
0.02%
EPS (TTM)
$-3.04
Revenue (TTM)
$502.08B
Return On Equity (TTM)
35.62%
Profit Margin
-144.39%
Debt to Equity
-1.49
Quarterly Earnings Growth YoY
56.96%

BridgeBio Pharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$154.18$194.52$243.68$353.17
Net Profit-$192.86-$164.04-$152.22-$83.00
Net Profit Margin-125.09%-84.33%-62.47%-23.50%
Income ChangeN/A14.94%7.21%45.47%

BridgeBio Pharma, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$77.65$9.30$221.90$502.08
Net Profit-$481.18-$643.20-$535.76-$724.93
Net Profit Margin-619.68%-6916.13%-241.44%-144.39%
Income ChangeN/A-33.67%16.70%-35.31%

About BridgeBio Pharma, Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

BridgeBio Pharma, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$74.99
$76.75
+2.45%
Oct 2026
$65.66
$74.92
+13.74%
Sep 2026
$77.13
$65.86
-16.33%
Aug 2026
$80.53
$78.72
-1.69%
Jul 2026
$74.59
$80.07
+7.48%
Jun 2026
$66.50
$74.50
+12.33%
May 2026
$70.25
$66.32
-6.81%
Apr 2026
$74.77
$71.17
-4.11%
Mar 2026
$64.71
$74.22
+11.68%
Feb 2026
$76.50
$66.46
-14.04%
Jan 2026
$76.92
$77.31
+1.05%
Dec 2025
$71.91
$76.51
+6.24%

BBIO Share Price FAQs